avelumab
pfizer,merck
['4560', 'urothelial', 'pfizer']
see an exploratory subgroup analysis of outcomes based on type of 2l treatment in patients w/ advanced #urothelialcancer who received 1l immunotherapy in a phase 3 study at #asco22 4560 
Dedicated to communicating emerging science from Pfizer Oncology. Please see our community guidelines: https://t.co/MU3blmItSZ